The pathogenesis of ALM involves two genetic mutation patterns: the first characterized by a t(4;5)(p12;q32) translocation producing the CARMN::TXK fusion gene; the second involves recurrent Xq22 rearrangements leading to IRS4 overexpression (8). The gene discussed is TXK; the disease is acral lentiginous melanoma.